Actively Recruiting
PEG Laxatives for Intestinal Preparation and Gut Microbiota in Cholecystectomy
Led by Tongji Hospital · Updated on 2026-02-27
20
Participants Needed
1
Research Sites
112 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study aims to investigate the impact of polyethylene glycol (PEG) laxatives used for bowel preparation on the gut microbiota of patients who have undergone cholecystectomy. Emerging evidence suggests that both cholecystectomy and high-dose PEG exposure can independently alter the intestinal microbial ecosystem. However, whether the microbiota of post-cholecystectomy patients is more vulnerable to PEG-induced perturbation and exhibits delayed recovery remains unknown. Approximately 10 adults with prior cholecystectomy scheduled for colonoscopy and 10 age-matched controls without cholecystectomy will be enrolled. All participants will undergo standard colonoscopy preparation with PEG-based laxatives. Stool samples will be collected at five time points: before bowel preparation, at the first non-watery stool after colonoscopy, and at 1, 3, and 6 months post-colonoscopy. Metagenomic shotgun sequencing will be performed to characterise the taxonomic and functional profiles of the gut microbiome. Alpha diversity, beta diversity, differential abundance, and metabolic pathway alterations will be compared within and between groups over time. The findings are expected to reveal whether cholecystectomised individuals are more susceptible to long-term gut dysbiosis after PEG exposure, and to inform future strategies for microbiota restoration in this specific population.
CONDITIONS
Official Title
PEG Laxatives for Intestinal Preparation and Gut Microbiota in Cholecystectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Scheduled to undergo colonoscopy with polyethylene glycol (PEG)-based bowel preparation.
- Prior cholecystectomy performed at least 6 months before enrolment (for the gallbladder removal group).
- Intact gallbladder with no history of cholecystectomy (for the control group).
- Willing and able to provide written informed consent.
- Willing to collect and mail stool samples at five specified time points (baseline, first non-watery stool after colonoscopy, 1 month, 3 months, 6 months).
You will not qualify if you...
- Contraindications to colonoscopy such as severe cardiopulmonary insufficiency, acute gastrointestinal bleeding, or severe coagulopathy.
- Known intolerance or allergy to polyethylene glycol (PEG).
- Use of antibiotics, probiotics, or prebiotics within 6 months prior to enrolment.
- Pregnancy or breastfeeding.
- Mental disorders or any condition impairing ability to comply with study procedures.
- Major organ diseases including liver cirrhosis, advanced chronic kidney disease, or uncontrolled diabetes mellitus.
- Participation in another interventional clinical trial within the last 3 months.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Gastroenterology Tongji Hospital, Tongji Medical college, Huazhong University of Science and technology
Wuhan, Hubei, China, 430030
Actively Recruiting
Research Team
P
ping h Xie
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here